Azienda Ospedaliera Universitaria Integrata Verona
Clinical trials sponsored by Azienda Ospedaliera Universitaria Integrata Verona, explained in plain language.
-
New heat treatment could replace surgery for rare pancreatic tumors
Disease control OngoingThis study compares a less invasive procedure called endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) with standard surgery for treating pancreatic insulinoma, a rare tumor that causes low blood sugar. About 60 adults with small tumors (≤2 cm) will be randomly assig…
Phase: NA • Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New biopsy test may predict pancreatic tumor danger
Knowledge-focused OngoingThis study looks at whether checking for two proteins, ATRX and DAXX, in biopsy samples can help predict how aggressive non-functional pancreatic neuroendocrine tumors (NF-pNETs) are. Researchers will compare biopsy results with surgical tissue from 100 adults to see if the test …
Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Can a simple heart test predict your next heart attack?
Knowledge-focused OngoingThis study looks back at medical records of 1,000 people who had a special test during a heart catheterization to measure blood flow in their heart arteries. Researchers want to see if the test results can predict future heart attacks, the need for another procedure, or death fro…
Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC